Salivary Interleukin - 6: Assessment In Chronic Generalized Periodontitis Patient With And Without Type 2 Diabetes Mellitus

  • Shreya Modi post graduate
  • Sumedha Srivastava
  • Veena Kalburgi
  • Sai Sri Harsha Nimmala
  • Anushri Gupta
  • Nida Malik
Keywords: Diabetes Mellitus ; Hemoglobin A glycosylated ; Interleukin -6 ; Chronic generalized periodontitis


Background: Periodontitis is affected by various systemic diseases, among them Diabetes Mellitus is a major systemic factor to influence the severity of chronic periodontitis. Various inflammatory markers are produced in the course of disease that can be reflected in saliva. This study evaluates the salivary concentration of interleukin-6 (IL - 6) in periodontitis patients with type 2 diabetes.

Materials and Methods: Whole saliva samples were collected from sixty four patients who were further divided into four groups; Healthy group (control group; n = 16), Chronic Generalized Periodontitis (PD; n = 16), Diabetes Mellitus (DM; n = 16), and Chronic Generalized Periodontitis along with Diabetes Mellitus (PD + DM; n = 16 patients). Salivary IL-6 concentrations were determined by standard enzyme-linked immunosorbent assay and Clinical parameters were recorded like Gingival Index (GI), Oral Hygiene Index (OHI-S), Probing Pocket Depth (PPD), Gingival Recession (GR), Clinical Attachment Level (CAL) with the help of mouth mirror and UNC -15 graduated periodontal probe.

Results: Result showed that the Chronic Generalized Periodontitis patients with and without Diabetes Mellitus exhibited higher concentrations of salivary IL-6 than the control group and diabetes groups. Further, the salivary IL-6 was correlated with glycosylated hemoglobin A levels in patient with diabetes. This is due to the fact that both Diabetes & Periodontitis are chronic inflammatory disease that significantly increase the expression of IL-6 which  cause insulin resistance in adipocyte and thereby affecting HbA1c levels. Therefore, both can affect severity of each other. Salivary concentration of IL‐6 was determined using an Human IL-6 (Interleukin- 6) ELISA Kit. Kruskal Wallis test was applied to compare any statistical difference between groups for clinical parameters, HbA1c and IL-6. Spearman correlation test was used to find any relation between HbA1c and IL -6 among all the groups. A significance level of 5% was set (P<0.05).


Conclusion: The salivary concentration of IL-6 was elevated in patients with periodontitis with and without diabetes. Therefore, levels of salivary IL-6 can be considered as an important biomarker in the diagnosis of periodontitis and diabetes.


1. Costa PP, Trevisan GL, Macedo GO, Palioto DB, Souza SL, Grisi MF, et al.
Salivary interleukin‐6, matrix metalloproteinase‐8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol 2010;81:384‐91.
2. Lu HK, Chen YL, Li CL, Kuo MY. Identification of the osteoprotegerin/receptor activator of nuclear factor kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res 2006;41:354-360.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus (position statement). Diabetes Care 2009;32:S62-S67.
4. Graves DT, Liu R, Oates TW. Diabetes-enhanced inflammation and apoptosis: Impact on periodontal pathosis. Periodontol 2000 2007;45:128-137.
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37:S81-S90.
6. Mealey BL. Diabetes and periodontal disease: Two sides of a coin. Compend Contin Educ Dent 2000;21:943‐6, 948, 950.
7. Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-1b and interleukin-10 levels in chronic periodontitis. J Dent 2004;32:511-520.
8. Cronstein BN. Interleukin-6: A key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007;65:S11-S15.
9. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, et al. Current Developments in Salivary Diagnostics. Biomark Med 2010;4:171–89.
10. Pellegrini GG, Gonzales CM, Somoza JC, Friedman SM, Zeni SN. Correlation between salivary and serum markers of bone turnover in osteopenic rats. J Periodontol 2008;79:158-165.
11. Ito T, Komiya-Ito A, Arataki T, et al. Relationship between antimicrobial protein levels in whole saliva and periodontitis. J Periodontol 2008;79:316-322.
12. Navazesh M. Methods for collecting saliva. Annals of the New York Academy of Sciences 1993;694:72-7.
13. Sheridan P. Diabetes and oral health. J Am Dent Assoc 1987;115:741-2. doi: 10.14219/jada.archive.1987.0293. PMID: 3479498.
14. Oliver RC, Tervonen T. Diabetes - A risk factor for periodontitis in adults? J Periodontal 1994;65:530–8.
15. Botero JE, Yepes FL, Roldán N, et al. Tooth and periodontal clinical attachment loss are associated with hyperglycemia in patients with diabetes. J Periodontol 2012; 83: 1245-1250.
16. Morita I, Inagaki K, Nakamura F, et al. Relationship between periodontal status and levels of glycated hemoglobin. J Dent Res 2012;91:161‐166. doi:10.1177/0022034511431583
17. Monea, A., T. Mezei, and M. Monea. Saliva and serum levels of TNF-α and IL- 6 in a sample of romanian adult subjects with type 2 diabetes mellitus and periodontal disease. European Scientific Journal 2012;53:491-5.
18. Masataka Nakamura , Shigeto Oda, Tomohito Sadahiro, Eizo Watanabe et al.
Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients. Critical Care 2012, 16:R58
19. Karjalainen KM, Knuuttila ML. The onset of diabetes and poor metabolic control increases gingival bleeding in children and adolescents with insulin dependent diabetes mellitus. J Clin Periodontal 1996;23:1060–7
20. Duarte PM, Neto JBC, Casati MZ, Sallum EA, Nociti FH Jr. Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis. Oral Dis 2007;13:594-599.
21. Rodrigues DC, Taba M Jr., Novaes AB Jr., Souza SL, Grisi MF. Effect of non- surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 2003;74:1361-1367.
22. Nesse W, Linde A, Abbas F, et al. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol 2009; 36: 295-300.
23. Hasaan Gassim Mohamed, Shaza Bushra Idris, Manal Mustafa, Mutaz Faisal Ahmed, Anne Nordrehaug Åstrøm, Kamal Mustafa. Influence of Type 2 Diabetes on Prevalence of Key Periodontal Pathogens, Salivary Matrix Metalloproteinases, and Bone Remodeling Markers in Sudanese Adults with and without Chronic Periodontitis. International Journal of Dentistry 2016;2016:6296854.
24. Scannapieco FA, Ng P, Hovey K, Hausmann E, Hutson A, Wactawski‐Wende
J. Salivary biomarkers associated with alveolar bone loss. Ann N Y Acad Sci 2007;1098:496‐7.
25. Bachu L, Siddiqui IA, Neha. Comparison of HbA1c and FBS among Diabetics and Non-diabetics to evaluate Role of HbA1c as a Screening Tool. Int J Med Res Rev 2013;1:125-130.
26. Lim LP, Tay FB, Sum CF, Thai AC. Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. J Clin Periodontol 2007;34:1
How to Cite
Modi, S., Srivastava, S., Kalburgi, V., Nimmala, S. S. H., Gupta, A., & Malik, N. (2021). Salivary Interleukin - 6: Assessment In Chronic Generalized Periodontitis Patient With And Without Type 2 Diabetes Mellitus. UNIVERSITY JOURNAL OF DENTAL SCIENCES, 7(2).